0000904454-18-000281.txt : 20180405
0000904454-18-000281.hdr.sgml : 20180405
20180405184955
ACCESSION NUMBER: 0000904454-18-000281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180403
FILED AS OF DATE: 20180405
DATE AS OF CHANGE: 20180405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIGHAM MICHAEL
CENTRAL INDEX KEY: 0001216917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 18741623
MAIL ADDRESS:
STREET 1: 890 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 807-6600
MAIL ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-04-03
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001216917
BIGHAM MICHAEL
C/O PARATEK PHARMACEUTICALS, INC.
75 PARK PLAZA, 4TH FLOOR
BOSTON
MA
02116
1
1
0
0
Chairman and CEO
Common Stock
2018-04-03
4
A
0
21750
0
A
208430
D
Represents performance-based restricted stock units granted on February 2, 2017 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on April 3, 2018.
/s/ William M. Haskel, Attorney-in-Fact for Michael Bigham
2018-04-05